Buffington Mohr Mc Neal Catalent, Inc. Transaction History

Buffington Mohr Mc Neal

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	SELL	$45.44 - $74.26 $90,880 - $148,520	-2,000 Reduced 22.48%	6,895 $453,000
Q4 2022 Jan 19, 2023	SELL	$41.39 - $81.0 $3.35 Million - $6.56 Million	-80,964 Reduced 90.1%	8,895 $0
Q3 2022 Oct 11, 2022	SELL	$72.36 - $113.1 $29,233 - $45,692	-404 Reduced 0.45%	89,859 $6.5 Million
Q2 2022 Jul 19, 2022	BUY	$87.2 - $114.05 $9,417 - $12,317	108 Added 0.12%	90,263 $9.68 Million
Q1 2022 May 02, 2022	BUY	$94.19 - $124.49 $357,451 - $472,439	3,795 Added 4.39%	90,155 $10 Million
Q4 2021 Jan 27, 2022	BUY	$119.57 - $139.07 $183,659 - $213,611	1,536 Added 1.81%	86,360 $11.1 Million
Q3 2021 Oct 13, 2021	SELL	$109.17 - $142.35 $163,209 - $212,813	-1,495 Reduced 1.73%	84,824 $11.3 Million
Q2 2021 Jul 28, 2021	BUY	$100.34 - $115.69 $87,496 - $100,881	872 Added 1.02%	86,319 $9.33 Million
Q1 2021 Apr 14, 2021	BUY	$101.51 - $125.27 $708,438 - $874,259	6,979 Added 8.89%	85,447 $9 Million
Q4 2020 Jan 20, 2021	BUY	$85.88 - $105.36 $817,319 - $1 Million	9,517 Added 13.8%	78,468 $8.17 Million
Q3 2020 Oct 26, 2020	BUY	$72.74 - $92.5 $2.53 Million - $3.21 Million	34,715 Added 101.4%	68,951 $5.91 Million
Q2 2020 Jul 27, 2020	BUY	$48.02 - $79.04 $98,248 - $161,715	2,046 Added 6.36%	34,236 $2.51 Million
Q1 2020 Apr 08, 2020	BUY	$36.95 - $62.95 $1.19 Million - $2.03 Million	32,190 New	32,190 $1.67 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Buffington Mohr Mc Neal, based on Form 13F filings with the SEC.

Stay updated on Buffington Mohr Mc Neal with notifications on news.